No Surprises for Endo Health in Paladin’s 3Q Results
Insights - There’s nothing worse for an acquirer than finding out that what they are buying is not what it seems. Good news for Endo Health (ENDP) … Continue Reading
Read nowSearch Results for endo health
Endo Health to Expand by Buying Paladin Labs
Insights - Moving from target to hunter, Endo Health (ENDP) announced plans to purchase Paladin Labs (PLB.TO), a Canadian specialty pharmaceutical manufacturer, for $1.5 billion. Both companies … Continue Reading
Read nowThe Market Likes Endo Health’s New Strategy: You Should Too
Long Ideas - Endo Health Solutions’ (ENDP) new CEO is executing on his strategy, as expected, and most of the Street likes what it sees. Endo announced on … Continue Reading
Read nowEndo Health’s New Exec Expected To Swing Right Into Action
Long Ideas - As we wrote last week, Endo Health’s (ENDP) newly appointed CEO and former Valeant (VRX) operating star Rajiv De Silva is on the road with … Continue Reading
Read nowEndo Health’s New CEO Will Be Revealing His Strategy – Good News for Investors?
Long Ideas - Chatter on the specialty pharma front is that Endo Health’s (ENDP) newly hired CEO will be shaking hands with shareholders in a multi-city road show … Continue Reading
Read nowEndo Health To Become The Next Valeant – or Part of Valeant
Long Ideas - Endo Pharmaceuticals (ENDP) named its new CEO Monday morning, Rajiv De Silva, who was formerly President and COO of Valeant Pharmaceuticals (VRX). In a January … Continue Reading
Read nowEverybody Wins If Endo Health Is Acquired by Warner Chilcott or Valeant
Long Ideas - Last week, a Reuters article indicated that Endo Health Solutions (ENDP) is exploring options to sell itself, citing Valeant Pharmaceuticals (VRX) and Warner Chilcott (WCRX) … Continue Reading
Read now